| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in clinical molecular imaging instrumentation
|
Hutton, Brian F.
|
|
2018
|
|
1 |
p. 31-45
|
artikel
|
| 2 |
Aerosolised micro and nanoparticle: formulation and delivery method for lung imaging
|
Munir, Miftakul
|
|
|
|
1 |
p. 33-50
|
artikel
|
| 3 |
Amyloid PET imaging: a challenge for research in clinical neuroimaging
|
Frey, Kirk
|
|
2015
|
|
1 |
p. 3-5
|
artikel
|
| 4 |
Amyloid PET imaging: applications beyond Alzheimer’s disease
|
Catafau, Ana M.
|
|
2015
|
|
1 |
p. 39-55
|
artikel
|
| 5 |
Artificial intelligence techniques support nuclear medicine modalities to improve the diagnosis of Parkinson’s disease and Parkinsonian syndromes
|
Palumbo, Barbara
|
|
|
|
1 |
p. 19-35
|
artikel
|
| 6 |
Assessment of response to treatment in paediatric bone sarcomas by means of PET imaging
|
Quartuccio, Natale
|
|
2016
|
|
1 |
p. 41-55
|
artikel
|
| 7 |
Beta-amyloid imaging with florbetaben
|
Sabri, Osama
|
|
2015
|
|
1 |
p. 13-26
|
artikel
|
| 8 |
Brain aerobic glycolysis functions and Alzheimer’s disease
|
Vlassenko, Andrei G.
|
|
2014
|
|
1 |
p. 27-37
|
artikel
|
| 9 |
Can visual illustrations transform the patient information sheet for PET/MR neuroimaging studies into an engaging and interesting reading?
|
Nordio, Giovanna
|
|
|
|
1 |
p. 1-4
|
artikel
|
| 10 |
Cardiac amyloidosis
|
Giorgetti, Assuero
|
|
2019
|
|
1 |
p. 21-32
|
artikel
|
| 11 |
Cardiovascular clinical applications of PET/MRI
|
Ratib, Osman
|
|
2013
|
|
1 |
p. 65-71
|
artikel
|
| 12 |
Change of management by using hybrid imaging with radiolabelled choline in biochemical recurrent prostate cancer: a systematic review and a meta-analysis
|
Ferrari, Matteo
|
|
|
|
1 |
p. 57-71
|
artikel
|
| 13 |
Clinical and translational imaging keeps growing: thanks to its board members, authors and readership
|
Lucignani, G.
|
|
2019
|
|
1 |
p. 1-2
|
artikel
|
| 14 |
Clinical and translational imaging: on a wave of progressive development
|
Lucignani, Giovanni
|
|
2016
|
|
1 |
p. 1-2
|
artikel
|
| 15 |
Clinical and Translational Imaging: reviews in nuclear medicine and molecular imaging
|
Lucignani, Giovanni
|
|
2013
|
|
1 |
p. 1-2
|
artikel
|
| 16 |
Clinical and Translational Imaging: the making of an international journal
|
Lucignani, Giovanni
|
|
2014
|
|
1 |
p. 1-3
|
artikel
|
| 17 |
Clinical and Translational Imaging: time for a major leap forward
|
Lucignani, Giovanni
|
|
2015
|
|
1 |
p. 1-2
|
artikel
|
| 18 |
Clinical and Translational Imaging two years after take-off
|
Lucignani, Giovanni
|
|
2015
|
|
1 |
p. 1-2
|
artikel
|
| 19 |
Clinical and translational imaging 2020: update on progresses thanks to readers and editors
|
Lucignani, Giovanni
|
|
|
|
1 |
p. 1-2
|
artikel
|
| 20 |
Clinicians’ perspectives on PET/CT in oncological patients: an Italian National Survey
|
Santo, Giulia
|
|
|
|
1 |
p. 99-107
|
artikel
|
| 21 |
Comprehensive meta-analysis on [18F] FDG PET/CT and radiolabelled leukocyte SPECT–SPECT/CT imaging in infectious endocarditis and cardiovascular implantable electronic device infections
|
Cantoni, Valeria
|
|
2018
|
|
1 |
p. 3-18
|
artikel
|
| 22 |
Correction: FDG–PET in patients with autoimmune encephalitis: a review of findings and new perspectives
|
Baldissin, Maurício Martins
|
|
|
|
1 |
p. 111
|
artikel
|
| 23 |
Current status and future perspectives of PET/MRI hybrid imaging
|
Picchio, Maria
|
|
2016
|
|
1 |
p. 79-81
|
artikel
|
| 24 |
Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neurites
|
Kotzbauer, Paul T.
|
|
2016
|
|
1 |
p. 3-14
|
artikel
|
| 25 |
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand?
|
Kirienko, Margarita
|
|
|
|
1 |
p. 37-55
|
artikel
|
| 26 |
Diagnostic efficacy of bone scintigraphy in transthyretin cardiac amyloidosis: an updated systematic review and Bayesian bivariate meta-analysis
|
Ruan, Dan
|
|
|
|
1 |
p. 85-98
|
artikel
|
| 27 |
Diagnostic role of 11C-methionine PET/CT in patients with multiple myeloma and other plasma cell malignancy: a literature review
|
Maccora, Daria
|
|
|
|
1 |
p. 3-17
|
artikel
|
| 28 |
Dose management in conventional nuclear medicine imaging and PET
|
Andersson, Martin
|
|
2016
|
|
1 |
p. 21-30
|
artikel
|
| 29 |
Dose optimization: a major challenge for acceptability of nuclear medicine
|
Guludec, Dominique Le
|
|
2016
|
|
1 |
p. 73-74
|
artikel
|
| 30 |
Dose optimization for myocardial perfusion CZT-SPECT imaging: Why and how?
|
Imbert, Laetitia
|
|
2015
|
|
1 |
p. 13-20
|
artikel
|
| 31 |
Dose optimization in nuclear medicine
|
Lassmann, M.
|
|
2016
|
|
1 |
p. 3-4
|
artikel
|
| 32 |
Dose optimization in nuclear medicine therapy of benign and malignant thyroid diseases
|
Hänscheid, H.
|
|
2015
|
|
1 |
p. 31-40
|
artikel
|
| 33 |
Dose optimization in pediatric nuclear medicine
|
Fahey, Frederic
|
|
2016
|
|
1 |
p. 5-11
|
artikel
|
| 34 |
Fair play: towards gender equality in nuclear medicine
|
Lasnon, Charline
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 35 |
False iodine-131 MIBG scintigraphy findings in adrenal tumors: correlation with MR imaging
|
Dell’Aversana, Serena
|
|
|
|
1 |
p. 109-115
|
artikel
|
| 36 |
FDG-PET/CT for diagnosis of cyst infection in autosomal dominant polycystic kidney disease
|
Pijl, J. P.
|
|
2018
|
|
1 |
p. 61-67
|
artikel
|
| 37 |
FDG–PET in patients with autoimmune encephalitis: a review of findings and new perspectives
|
Baldissin, Maurício Martins
|
|
|
|
1 |
p. 15-30
|
artikel
|
| 38 |
18F-FDG PET/CT role in Burkitt lymphoma
|
Albano, Domenico
|
|
|
|
1 |
p. 39-45
|
artikel
|
| 39 |
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis
|
Bezzi, Carolina
|
|
|
|
1 |
p. 45-58
|
artikel
|
| 40 |
18F-Florbetaben: a potential nuclear protagonist in the diagnosis of cardiac amyloidosis
|
Genovesi, Dario
|
|
|
|
1 |
p. 5-8
|
artikel
|
| 41 |
18F-FMISO PET imaging: insights over MRI in patients with glioma
|
Riccardo, Laudicella
|
|
|
|
1 |
p. 3-10
|
artikel
|
| 42 |
18F-FMISO PET imaging: insights over MRI in patients with glioma
|
Riccardo, Laudicella
|
|
|
|
1 |
p. 3-10
|
artikel
|
| 43 |
Head-to-head comparison between 18F-FDG PET/low-dose CT and 18F-FDG PET/contrast-enhanced CT in relapsing ovarian carcinoma: a systematic review and meta-analysis
|
Massollo, Michela
|
|
|
|
1 |
p. 73-81
|
artikel
|
| 44 |
High-field PET/MRI and MRS: potential clinical and research applications
|
Panebianco, Valeria
|
|
2013
|
|
1 |
p. 17-29
|
artikel
|
| 45 |
HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer
|
Pozzo, Lorena
|
|
2019
|
|
1 |
p. 7-20
|
artikel
|
| 46 |
Hybrid PET/MRI imaging in non-ischemic cardiovascular disease
|
Argalia, Giulia
|
|
|
|
1 |
p. 69-80
|
artikel
|
| 47 |
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers
|
Quartuccio, Natale
|
|
|
|
1 |
p. 11-20
|
artikel
|
| 48 |
Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes
|
Frey, Kirk A.
|
|
2015
|
|
1 |
p. 57-64
|
artikel
|
| 49 |
Imaging as a pharmacodynamic and response biomarker in cancer
|
Merchant, Shairoz
|
|
2014
|
|
1 |
p. 13-31
|
artikel
|
| 50 |
Imaging fungal infections in children
|
Ankrah, Alfred O.
|
|
2016
|
|
1 |
p. 57-72
|
artikel
|
| 51 |
Imaging gastrin-releasing peptide receptors (GRPRs) in prostate cancer
|
Baratto, Lucia
|
|
2018
|
|
1 |
p. 39-44
|
artikel
|
| 52 |
Imaging of molecular target modulation in oncology: challenges of early clinical trials
|
Cullinane, Carleen
|
|
2014
|
|
1 |
p. 5-12
|
artikel
|
| 53 |
Impact of PSMA PET on management of biochemical recurrent prostate cancer: a systematic review and meta-analysis of prospective studies
|
Liu, Ao
|
|
|
|
1 |
p. 95-108
|
artikel
|
| 54 |
Insights into cognitive aging and Alzheimer’s disease using amyloid PET and structural MRI scans
|
Duara, Ranjan
|
|
2015
|
|
1 |
p. 65-74
|
artikel
|
| 55 |
Letter to the Editor: Timing of diuretics in diuresis renography
|
Perera Molligoda Arachchige, Arosh S.
|
|
|
|
1 |
p. 99
|
artikel
|
| 56 |
Liquid biopsies and molecular imaging: friends or foes?
|
Carrió, Ignasi
|
|
|
|
1 |
p. 47-50
|
artikel
|
| 57 |
Mechanistic and high-throughput approaches for the design of molecular imaging probes and targeted therapeutics
|
Haberkorn, Uwe
|
|
2014
|
|
1 |
p. 33-41
|
artikel
|
| 58 |
Molecular imaging and fusion targeted biopsy of the prostate
|
Fei, Baowei
|
|
2016
|
|
1 |
p. 29-43
|
artikel
|
| 59 |
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
|
Iommelli, F.
|
|
2014
|
|
1 |
p. 43-53
|
artikel
|
| 60 |
Molecular neuroimaging with PET/MRI
|
Garibotto, V.
|
|
2013
|
|
1 |
p. 53-63
|
artikel
|
| 61 |
Multimodality imaging for diagnosis, risk stratification, and treatment monitoring of cardiac sarcoidosis
|
Young, Kathleen A.
|
|
|
|
1 |
p. 55-68
|
artikel
|
| 62 |
Nanomedicine technology: current achievements and new trends
|
Fattal, Elias
|
|
2014
|
|
1 |
p. 77-87
|
artikel
|
| 63 |
Nuclear medicine and immunotherapy: many questions but not many answers yet
|
Annunziata, Salvatore
|
|
2019
|
|
1 |
p. 3-5
|
artikel
|
| 64 |
Nuclear medicine techniques in transplantation
|
Lovinfosse, Pierre
|
|
2016
|
|
1 |
p. 45-62
|
artikel
|
| 65 |
Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
|
Coenen, Heinz H.
|
|
2019
|
|
1 |
p. 61-63
|
artikel
|
| 66 |
Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
|
Bison, Sander M.
|
|
2014
|
|
1 |
p. 55-66
|
artikel
|
| 67 |
PET/CT and urinary cancers: the message from urologists
|
Zattoni, Fabio
|
|
2018
|
|
1 |
p. 69-71
|
artikel
|
| 68 |
PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool?
|
Fonteyne, Valérie
|
|
|
|
1 |
p. 83-94
|
artikel
|
| 69 |
PET in brain tumors
|
Donner, Davide
|
|
2018
|
|
1 |
p. 45-60
|
artikel
|
| 70 |
PET/MR for evaluation of musculoskeletal malignancies
|
Husseini, Jad S.
|
|
|
|
1 |
p. 71-83
|
artikel
|
| 71 |
PET/MRI
|
Picchio, Maria
|
|
2013
|
|
1 |
p. 3-4
|
artikel
|
| 72 |
PET/MRI: a new era in multimodality molecular imaging
|
Ratib, Osman
|
|
2013
|
|
1 |
p. 5-10
|
artikel
|
| 73 |
PET/MRI in breast cancer
|
Vogel, W. V.
|
|
2016
|
|
1 |
p. 71-78
|
artikel
|
| 74 |
PET myocardial perfusion quantification: anatomy of a spreading functional technique
|
Juarez-Orozco, L. E.
|
|
2018
|
|
1 |
p. 47-60
|
artikel
|
| 75 |
PET receptor imaging in breast cancer
|
Sarikaya, Ismet
|
|
|
|
1 |
p. 5-13
|
artikel
|
| 76 |
Pharmacological protection of the thyroid gland against radiation damage from radioactive iodine labeled compounds in children: a systematic review
|
de Lijster, Bas
|
|
|
|
1 |
p. 71-82
|
artikel
|
| 77 |
Potential role of PET/MRI in radiotherapy treatment planning
|
Thorwarth, Daniela
|
|
2013
|
|
1 |
p. 45-51
|
artikel
|
| 78 |
Preliminary study of a novel FAP-targeted ligand 68Ga-DOTA-FL in colon cancer imaging using small-animal PET/CT
|
Xu, Zhan
|
|
|
|
1 |
p. 91-97
|
artikel
|
| 79 |
Progressive growth in publishing and sharing medical science
|
Lucignani, Giovanni
|
|
2018
|
|
1 |
p. 1-2
|
artikel
|
| 80 |
PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management
|
Claes, Pieter
|
|
|
|
1 |
p. 31-54
|
artikel
|
| 81 |
Quantitative analysis in Parathyroid scintigraphy: [99mTc]Tc-MIBI SPECT/CT a tool for noninvasive characterization of parathyroid lesions
|
Bashir, Sidra
|
|
|
|
1 |
p. 81-89
|
artikel
|
| 82 |
Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay
|
Airò Farulla, Lighea Simona
|
|
|
|
1 |
p. 95-106
|
artikel
|
| 83 |
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement?
|
Guglielmo, Priscilla
|
|
|
|
1 |
p. 1-2
|
artikel
|
| 84 |
Radiolabeled somatostatin analogues for the diagnosis and therapy of NETs: upcoming new strategies
|
Mansi, Luigi
|
|
|
|
1 |
p. 21-27
|
artikel
|
| 85 |
Regulatory approval and insurance reimbursement: the final steps in clinical translation of amyloid brain imaging
|
Herscovitch, Peter
|
|
2015
|
|
1 |
p. 75-77
|
artikel
|
| 86 |
Reply to Perera Molligoda Arachchige AS [1]
|
Laudicella, Riccardo
|
|
|
|
1 |
p. 109-110
|
artikel
|
| 87 |
Siderophores for molecular imaging applications
|
Petrik, Milos
|
|
2016
|
|
1 |
p. 15-27
|
artikel
|
| 88 |
Somatostatin receptor PET/MRI for the evaluation of neuroendocrine tumors
|
Hope, Thomas A.
|
|
2016
|
|
1 |
p. 63-69
|
artikel
|
| 89 |
Technical and methodological aspects of PET/MR
|
Ziegler, Sibylle I.
|
|
2013
|
|
1 |
p. 11-16
|
artikel
|
| 90 |
The clinical utility of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in guiding myocardial revascularisation
|
Mpanya, Dineo
|
|
|
|
1 |
p. 9-22
|
artikel
|
| 91 |
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC)
|
Morbelli, Silvia
|
|
|
|
1 |
p. 29-38
|
artikel
|
| 92 |
The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
|
Seifert, Robert
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 93 |
Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine
|
Jokar, Narges
|
|
|
|
1 |
p. 51-70
|
artikel
|
| 94 |
The role of 18F-FDG PET/CT in abdominal and pelvic leiomyosarcoma: a literature review
|
Lorusso, Margherita
|
|
|
|
1 |
p. 23-32
|
artikel
|
| 95 |
The theranostic path to personalized nanomedicine
|
Theek, Benjamin
|
|
2014
|
|
1 |
p. 67-76
|
artikel
|
| 96 |
The use of amyloid imaging in clinical praxis: a critical review
|
Nordberg, Agneta
|
|
2015
|
|
1 |
p. 7-11
|
artikel
|
| 97 |
The utilization of positron emission tomography in the evaluation of renal health and disease
|
Amoabeng, Kwame Anokye
|
|
|
|
1 |
p. 59-69
|
artikel
|
| 98 |
Timing of diuretics in diuresis renography
|
Bäck, Anna-Karin
|
|
|
|
1 |
p. 37-43
|
artikel
|
| 99 |
Towards consensus in acquisition and image analysis of PET and SPECT in the assessment of cardiac sympathetic innervation: a mini-review
|
Noordzij, Walter
|
|
2019
|
|
1 |
p. 33-38
|
artikel
|
| 100 |
Ultrasmall iron oxide nanoparticles and gadolinium-based contrast agents in magnetic resonance imaging: a systematic review and meta-analysis
|
Amraee, Azadeh
|
|
|
|
1 |
p. 83-93
|
artikel
|
| 101 |
Ultrasound and microbubbles for treatment purposes: mechanisms and results
|
Tranquart, F.
|
|
2014
|
|
1 |
p. 89-97
|
artikel
|
| 102 |
Value of FDG-PET/CT for treatment response in tuberculosis: a systematic review and meta-analysis
|
Sjölander, Hannes
|
|
2017
|
|
1 |
p. 19-29
|
artikel
|
| 103 |
Value of FDG-PET/CT for treatment response in tuberculosis: a systematic review and meta-analysis
|
Sjölander, Hannes
|
|
|
|
1 |
p. 19-29
|
artikel
|
| 104 |
“We ask the ascetics to come down from the columns…”
|
Burroni, Luca
|
|
|
|
1 |
p. 107
|
artikel
|
| 105 |
Whole-body PET/MRI in oncology: current status and clinical applications
|
Pace, Leonardo
|
|
2013
|
|
1 |
p. 31-44
|
artikel
|
| 106 |
Whole-body tumor burden in PET/CT expert review
|
Santos, Dihego F.
|
|
|
|
1 |
p. 5-22
|
artikel
|
| 107 |
89Zr-PET imaging in humans: a systematic review
|
De Feo, Maria Silvia
|
|
|
|
1 |
p. 23-36
|
artikel
|
Tijdschrift beschrijving